Letter

Subject to many potential biases

BMJ 1995; 311 doi: 10.1136/bmj.311.7015.1303c (Published 11 November 1995)
Cite this as: BMJ 1995;311:1303.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Simon Gilbody,
  2. Allan House,
  3. Fujian Song,
  4. Trevor Sheldon

    EDITOR,--I M Anderson and B M Tomenson's paper1 updates our meta-analysis comparing drop out rates in patients taking selective serotonin reuptake inhibitors and tricyclic antidepressants2 but excludes newer tricyclic drugs. Despite this difference, which would tend to favour the selective serotonin reuptake inhibitors, the results are nearly identical. The table compares drop out rates in the three published meta-analyses.1 2 3 Clearly, despite the different inclusion criteria, the results broadly agree: the difference is small and of dubious clinical and economic importance.

    View this table:
    • In this window
    • In a new window
    TABLE

    Drop out rates …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular